HYTEM for Cancer is a concept and treatment modality centered around the EMRF hyperthermia technology which has been in clinical application as an adjunct treatment for several cancers with a track record of safety and efficacy in Japan for more than three decades.

This is promoted by M/s GN Corporation Co Ltd., a Japanese firm promoting several state-of-the art concepts and superior technologies as well as products from Japan to the rest of the world for human welfare.

We provide logistics, operational and maintenance support to this technology through our partners in each territory.

A comprehensive presentation on Hyperthermia in detail can be made available upon request.